Clinical Trials Directory

Trials / Completed

CompletedNCT07307820

Sutureless Glueless Technique Versus Interrupted Suturing for Conjunctival Autograft Fixation After Primary Pterygium Excision: Anterior Segment Optical Coherence Tomography (ASOCT) Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Minia University · Academic / Other
Sex
All
Age
60 Years
Healthy volunteers
Not accepted

Summary

This study aims to compare the clinical and Anterior segment optical coherence tomography (ASOCT) outcomes between sutured and sutureless conjunctival autograft fixation techniques in the management of primary pterygium. A total of 30 patients with bilateral primary pterygia were included. Each patient underwent pterygium excision in both eyes: one eye received graft fixation using interrupted 10-0 nylon sutures, while the fellow eye received sutureless fixation. Allocation of technique between eyes was randomized. All surgeries were performed by the same surgeon, and patients were followed up weekly for one month. Parameters assessed included graft thickness, interface reflectivity, gutter size, conjunctival congestion, donor site healing, and postoperative discomfort using a visual analogue scale. The study evaluates which fixation method provides faster healing, better cosmetic results, and fewer complications such as graft slippage or recession, especially in relation to pterygium size.

Conditions

Interventions

TypeNameDescription
PROCEDUREsutured conjunctival autograft fixationAfter pterygium excision, a conjunctival autograft is secured in place using interrupted 10-0 nylon sutures to ensure graft stability and promote healing
PROCEDURESutureless Conjunctival Autograft FixationFollowing pterygium excision, the conjunctival autograft is placed without sutures, relying on natural adhesion and fibrin clot formation to maintain graft position.

Timeline

Start date
2025-09-01
Primary completion
2025-11-15
Completion
2025-12-01
First posted
2025-12-29
Last updated
2025-12-29

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT07307820. Inclusion in this directory is not an endorsement.